Vascularized 3D printed scaffolds for promoting bone regeneration.
暂无分享,去创建一个
Niklas Sandler | Jin Qi | Yu Shrike Zhang | Ruoyu Cheng | Haokai Shen | Y. S. Zhang | Lianfu Deng | N. Sandler | Hongbo Zhang | L. Deng | W. Cui | Ruoyu Cheng | Yufei Yan | Hongbo Zhang | Wenguo Cui | Kai Yang | Niandong Qian | Hao Chen | Yufei Yan | Changjun Guo | Kaizhe Chen | Changjun Guo | Kai Yang | N. Qian | J. Qi | Hao Chen | Kaizhe Chen | Haokai Shen
[1] D. Kaplan,et al. Injectable hydrogel systems with multiple biophysical and biochemical cues for bone regeneration. , 2020, Biomaterials science.
[2] Dong Zhai,et al. Three-Dimensional Printing of Hollow-Struts-Packed Bioceramic Scaffolds for Bone Regeneration. , 2015, ACS applied materials & interfaces.
[3] A. Akbarzadeh,et al. Assessment of polycaprolacton (PCL) nanocomposite scaffold compared with hydroxyapatite (HA) on healing of segmental femur bone defect in rabbits , 2017, Artificial cells, nanomedicine, and biotechnology.
[4] K. Kozloff,et al. Deferoxamine Restores Callus Size, Mineralization, and Mechanical Strength in Fracture Healing after Radiotherapy , 2013, Plastic and reconstructive surgery.
[5] Chao Wan,et al. The hypoxia-inducible factor alpha pathway couples angiogenesis to osteogenesis during skeletal development. , 2007, The Journal of clinical investigation.
[6] S. Kang,et al. Bone-Healing Capacity of PCL/PLGA/Duck Beak Scaffold in Critical Bone Defects in a Rabbit Model , 2016, BioMed research international.
[7] Ivan Martin,et al. Angiogenesis in tissue engineering: breathing life into constructed tissue substitutes. , 2006, Tissue engineering.
[8] J. Porter. Deferoxamine pharmacokinetics. , 2001, Seminars in hematology.
[9] Xiaofeng Jia,et al. Engineering anatomically shaped vascularized bone grafts with hASCs and 3D-printed PCL scaffolds. , 2014, Journal of biomedical materials research. Part A.
[10] P. Carmeliet,et al. Adequate hypoxia inducible factor 1α signaling is indispensable for bone regeneration. , 2016, Bone.
[11] Chao Wan,et al. Prolyl hydroxylase inhibitors increase neoangiogenesis and callus formation following femur fracture in mice , 2009, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.
[12] Jieun Jung,et al. Hypoxia Inducible Factor-1α Regulates the Migration of Bone Marrow Mesenchymal Stem Cells via Integrin α 4 , 2016, Stem cells international.
[13] Haiyan Wang,et al. Hypoxia-inducible factor-1α antagonizes the hypoxia-mediated osteoblast cell viability reduction by inhibiting apoptosis. , 2015, Experimental and therapeutic medicine.
[14] R. Adams,et al. Coupling of angiogenesis and osteogenesis by a specific vessel subtype in bone , 2014, Nature.
[15] L. Deng,et al. Desferrioxamine reduces ultrahigh-molecular-weight polyethylene-induced osteolysis by restraining inflammatory osteoclastogenesis via heme oxygenase-1 , 2016, Cell Death and Disease.
[16] A. Donneys,et al. Targeting angiogenesis as a therapeutic means to reinforce osteocyte survival and prevent nonunions in the aftermath of radiotherapy , 2015, Head & neck.
[17] J. Barralet,et al. * Hypoxia Biomimicry to Enhance Monetite Bone Defect Repair. , 2017, Tissue engineering. Part A.
[18] Peng Jia,et al. Deferoxamine released from poly(lactic-co-glycolic acid) promotes healing of osteoporotic bone defect via enhanced angiogenesis and osteogenesis. , 2016, Journal of biomedical materials research. Part A.
[19] P. Bártolo,et al. Effect of process parameters on the morphological and mechanical properties of 3D Bioextruded poly(ε‐caprolactone) scaffolds , 2012 .
[20] Benjamin M Wu,et al. Recent advances in 3D printing of biomaterials , 2015, Journal of Biological Engineering.
[21] S. Buchman,et al. Reply: deferoxamine restores callus size, mineralization, and mechanical strength in fracture healing after radiotherapy. , 2013, Plastic and reconstructive surgery.
[22] R. Najafi,et al. Deferoxamine preconditioning potentiates mesenchymal stem cell homing in vitro and in streptozotocin-diabetic rats , 2013, Expert opinion on biological therapy.
[23] W. Świȩszkowski,et al. Three‐dimensional printed polycaprolactone‐based scaffolds provide an advantageous environment for osteogenic differentiation of human adipose‐derived stem cells , 2018, Journal of tissue engineering and regenerative medicine.
[24] T. Miramond,et al. Osteoconduction, Osteogenicity, Osteoinduction, what are the fundamental properties for a smart bone substitutes , 2013 .
[25] P. Babu,et al. Isolation, characterization and differentiation potential of rat bone marrow stromal cells. , 2010, Neurology India.
[26] Feng Chen,et al. Enhanced osteogenesis and angiogenesis by mesoporous hydroxyapatite microspheres-derived simvastatin sustained release system for superior bone regeneration , 2017, Scientific Reports.
[27] Warren L. Grayson,et al. Comparison of 3D-Printed Poly-ɛ-Caprolactone Scaffolds Functionalized with Tricalcium Phosphate, Hydroxyapatite, Bio-Oss, or Decellularized Bone Matrix. , 2016, Tissue engineering. Part A.
[28] A. Martínez-Richa,et al. Hydrolytic degradation of poly(ε‐caprolactone) with different end groups and poly(ε‐caprolactone‐co‐γ‐butyrolactone): characterization and kinetics of hydrocortisone delivery , 2011 .
[29] Richard O C Oreffo,et al. The effect of the delivery of vascular endothelial growth factor and bone morphogenic protein-2 to osteoprogenitor cell populations on bone formation. , 2010, Biomaterials.
[30] Shaobing Zhou,et al. In Situ Growth Kinetics of Hydroxyapatite on Electrospun Poly(DL-lactide) Fibers with Gelatin Grafted , 2008 .
[31] M. Hadjiargyrou,et al. Activation of the transcription factor HIF-1 and its target genes, VEGF, HO-1, iNOS, during fracture repair. , 2004, Bone.
[32] J. Kanczler,et al. Osteogenesis and angiogenesis: the potential for engineering bone. , 2008, European cells & materials.
[33] Guangyao Liu,et al. Engineered three-dimensional scaffolds for enhanced bone regeneration in osteonecrosis , 2020, Bioactive materials.
[34] T. Clemens,et al. Activation of the hypoxia-inducible factor-1α pathway accelerates bone regeneration , 2008, Proceedings of the National Academy of Sciences.
[35] Jianzhong Fu,et al. 3D robocasting magnesium-doped wollastonite/TCP bioceramic scaffolds with improved bone regeneration capacity in critical sized calvarial defects. , 2017, Journal of materials chemistry. B.
[36] S. Goldstein,et al. Localized deferoxamine injection augments vascularity and improves bony union in pathologic fracture healing after radiotherapy. , 2013, Bone.
[37] Yong-ping Su,et al. Megakaryocytes promote bone formation through coupling osteogenesis with angiogenesis by secreting TGF-β1 , 2020, Theranostics.
[38] D. Hutmacher,et al. The return of a forgotten polymer : Polycaprolactone in the 21st century , 2009 .
[39] Richard O C Oreffo,et al. Bone tissue engineering: hope vs hype. , 2002, Biochemical and biophysical research communications.
[40] Molly M. Stevens,et al. Biomaterials for bone tissue engineering , 2008 .
[41] M. Álvarez-Pérez,et al. Polycaprolactone- and polycaprolactone/ceramic-based 3D-bioplotted porous scaffolds for bone regeneration: A comparative study. , 2017, Materials science & engineering. C, Materials for biological applications.
[42] N. Shahrubudin,et al. Challenges of 3D printing technology for manufacturing biomedical products: A case study of Malaysian manufacturing firms , 2020, Heliyon.
[43] Bin Zhang,et al. Effects of deferoxamine on the osteogenic differentiation of human periodontal ligament cells. , 2017, Molecular medicine reports.
[44] K. Burg,et al. Biomaterial developments for bone tissue engineering. , 2000, Biomaterials.
[45] K. Kozloff,et al. Prevention of radiation-induced bone pathology through combined pharmacologic cytoprotection and angiogenic stimulation. , 2016, Bone.
[46] Youjia Xu,et al. Synergistic protection of bone vasculature and bone mass by desferrioxamine in osteoporotic mice , 2017, Molecular medicine reports.
[47] R. Zellweger,et al. BONE MORPHOGENETIC PROTEINS IN CLINICAL APPLICATIONS , 2007, ANZ journal of surgery.
[48] Shaobing Zhou,et al. Controllable growth of hydroxyapatite on electrospun poly(dl-lactide) fibers grafted with chitosan as potential tissue engineering scaffolds , 2010 .
[49] B. He,et al. BMP9 exhibits dual and coupled roles in inducing osteogenic and angiogenic differentiation of mesenchymal stem cells , 2020, Bioscience reports.
[50] Karim Oudina,et al. Desferrioxamine‐driven upregulation of angiogenic factor expression by human bone marrow stromal cells , 2008, Journal of tissue engineering and regenerative medicine.
[51] Yi-Chih Sun,et al. VEGF modulates angiogenesis and osteogenesis in shockwave-promoted fracture healing in rabbits. , 2011, The Journal of surgical research.
[52] J. Richtsmeier,et al. Angiogenesis and intramembranous osteogenesis , 2013, Developmental dynamics : an official publication of the American Association of Anatomists.
[53] I Zein,et al. Mechanical properties and cell cultural response of polycaprolactone scaffolds designed and fabricated via fused deposition modeling. , 2001, Journal of biomedical materials research.
[54] E. Place,et al. Complexity in biomaterials for tissue engineering. , 2009, Nature materials.
[55] S. Buchman,et al. Deferoxamine Enhances Bone Regeneration in Mandibular Distraction Osteogenesis , 2014, Plastic and reconstructive surgery.
[56] L. Deng,et al. Mechanically enhanced lipo-hydrogel with controlled release of multi-type drugs for bone regeneration , 2018, Applied Materials Today.
[57] LiuLi-min,et al. In Situ Release of VEGF Enhances Osteogenesis in 3D Porous Scaffolds Engineered with Osterix-Modified Adipose-Derived Stem Cells. , 2017, Tissue engineering. Part A.
[58] P. Mohanan,et al. Degradation of Poly(ε-caprolactone) and bio-interactions with mouse bone marrow mesenchymal stem cells. , 2018 .
[59] Raquel Couto de Azevedo Gonçalves Mota,et al. 3D Printed Scaffolds as a New Perspective for Bone Tissue Regeneration: Literature Review , 2016 .
[60] A. Giaccia,et al. Age Decreases Endothelial Progenitor Cell Recruitment Through Decreases in Hypoxia-Inducible Factor 1α Stabilization During Ischemia , 2007, Circulation.
[61] G. Semenza,et al. Hypoxia-Inducible Factor 1 (HIF-1) Pathway , 2007, Science's STKE.
[62] T. Albrektsson,et al. Osteoinduction, osteoconduction and osseointegration , 2001, European Spine Journal.